Search Results - Tremblay, Gabriel

Refine Results
  1. 1
    US Budget Impact Model for Selinexor, Bortezomib, and Dexamethasone for the Treatment of Previously Treated Multiple Myeloma

    US Budget Impact Model for Selinexor, Bortezomib, and Dexamethasone for the Treatment of Previously Treated Multiple Myeloma by Dolph, Mike, Tremblay, Gabriel, Leong, Hoyee

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Cost Effectiveness of Triplet Selinexor-Bortezomib-Dexamethasone (XVd) in Previously Treated Multiple Myeloma (MM) Based on Results from the Phase III BOSTON Trial

    Cost Effectiveness of Triplet Selinexor-Bortezomib-Dexamethasone (XVd) in Previously Treated Multiple Myeloma (MM) Based on Results from the Phase III BOSTON Trial by Dolph, Michael, Tremblay, Gabriel, Leong, Hoyee

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons

    Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Compariso... by Tremblay, Gabriel, Tomaras, Dimitrios, Strati, Eric, Forsythe, Anna

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma

    Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma by Dolph, Michael, Tremblay, Gabriel, Gilligan, Adrienne M, Leong, Hoyee

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer

    Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory... by Tremblay, Gabriel, Livings, Christopher, Crowe, Lydia, Kapetanakis, Venediktos, Briggs, Andrew

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Cost-effectiveness analysis for midostaurin versus standard of care in acute myeloid leukemia in the United Kingdom

    Cost-effectiveness analysis for midostaurin versus standard of care in acute myeloid leukemia in the United Kingdom by Tremblay, Gabriel, Dolph, Mike, Patel, Sachin, Brandt, Patricia, Forsythe, Anna

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    HIGHLY METHYL ESTERIFIED SEEDS Is a Pectin Methyl Esterase Involved in Embryo Development

    HIGHLY METHYL ESTERIFIED SEEDS Is a Pectin Methyl Esterase Involved in Embryo Development by Levesque-Tremblay, Gabriel, Müller, Kerstin, Mansfield, Shawn D., Haughn, George W.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea

    Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea by Tremblay, Gabriel, Majethia, Unnati, Breeze, Janis L, Kontoudis, Ilias, Park, Jeongae

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2− metastatic breast cancer

    Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2− metastatic breast cancer by Forsythe, Anna, Chandiwana, David, Barth, Janina, Thabane, Marroon, Baeck, Johan, Tremblay, Gabriel

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer

    Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer by Tremblay, Gabriel, Chandiwana, David, Dolph, Mike, Hearnden, Jaclyn, Forsythe, Anna, Monaco, Mauricio

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia

    Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia by Tremblay, Gabriel, Dolph, Mike, Bhor, Menaka, Said, Qayyim, Elliott, Brian, Briggs, Andrew

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting

    Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting by Tremblay, Gabriel, Rousseau, Ben, Marquis, Miriam, Beaubois, Cyrielle, Sauvageau, Guy, Hébert, Josée

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Humanistic and Economic Burden of Conversion Therapy Among LGBTQ Youths in the United States

    Humanistic and Economic Burden of Conversion Therapy Among LGBTQ Youths in the United States by Forsythe, Anna, Pick, Casey, Tremblay, Gabriel, Malaviya, Shreena, Green, Amy, Sandman, Karen

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients

    Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients by Punekar, Yogesh Suresh, Guo, Na, Tremblay, Gabriel, Piercy, James, Holbrook, Tim, Young, Benjamin

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Systematic review of health state utility values for acute myeloid leukemia

    Systematic review of health state utility values for acute myeloid leukemia by Forsythe, Anna, Brandt, Patricia S, Dolph, Mike, Patel, Sachin, Rabe, Adrian Paul J, Tremblay, Gabriel

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer?

    Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer? by Forsythe, Anna, Chandiwana, David, Barth, Janina, Thabane, Marroon, Baeck, Johan, Shor, Anastasiya, Tremblay, Gabriel

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia

    Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia by Tremblay, Gabriel, Dolph, Mike, Bhor, Menaka, Said, Qayyim, Roy, Anuja, Elliott, Brian, Briggs, Andrew

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Indirect treatment comparisons including network meta-analysis: Lenvatinib plus everolimus for the second-line treatment of advanced/metastatic renal cell carcinoma

    Indirect treatment comparisons including network meta-analysis: Lenvatinib plus everolimus for the second-line treatment of advanced/metastatic renal cell carcinoma by Tremblay, Gabriel, McElroy, Heather J., Westley, Tracy, Meier, Genevieve, Misurski, Derek, Guo, Matthew

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Overexpression of a pectin methylesterase inhibitor in Arabidopsis thaliana leads to altered growth morphology of the stem and defective organ separation

    Overexpression of a pectin methylesterase inhibitor in Arabidopsis thaliana leads to altered growth morphology of the stem and defective organ separation by Müller, Kerstin, Levesque-Tremblay, Gabriel, Fernandes, Anwesha, Wormit, Alexandra, Bartels, Sebastian, Usadel, Bjoern, Kermode, Allison

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons

    Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness usi... by Tremblay, Gabriel, Westley, Tracy, Cappelleri, Joseph C, Arondekar, Bhakti, Chan, Geoffrey, Bell, Timothy J, Briggs, Andrew

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: